MAPK-IN-4

• Target:

  Interleukin|||p38 MAPK|||IRAK

• Related Pathways:

  MAPK|||Immunology/Inflammation|||NF-?B

• Bioactivity:

  MAPK-IN-4 (Compound c1) is an orally active anti-inflammatory agent that inhibits the expression and release of pro-inflammatory cytokines IL-6 and TNF-? induced by LPS. It interacts with IRAK4 to exert its anti-inflammatory effects by inhibiting the MAPK pathway.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C